Umeclidinium bromide/vilanterol

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Umeclidinium bromide/vilanterol
Umeclidinium bromide and vilanterol.svg
Umeclidinium bromide (TOP), vilanterol (BOTTOM)
Combination of
Umeclidinium bromide Muscarinic antagonist
Vilanterol Ultra-long-acting β2 agonist
Clinical data
Trade names Anoro Ellipta
AHFS/ anoro-ellipta
License data
  • US: C (Risk not ruled out)
Routes of
Inhalation (DPI)
ATC code
Legal status
Legal status

Umeclidinium bromide/vilanterol (trade name Anoro Ellipta) is a combination drug approved for the treatment of chronic obstructive pulmonary disease (COPD).[1][2] It is applied as an inhalation.


  1. ^ Feldman, GJ; Edin, A (2013). "The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: Current evidence and future prospects". Therapeutic advances in respiratory disease. 7 (6): 311–9. doi:10.1177/1753465813499789. PMID 24004659. 
  2. ^ "FDA Approves Umeclidinium and Vilanterol Combo for COPD". Medscape. December 18, 2013.